Global Brass & Copper Holdings Inc (BRSS) Jumps 5.16% on January 29

Equities Staff |

Global Brass & Copper Holdings Inc (BRSS) was among the biggest gainers on the Russell 2000 for Friday January 29 as the stock popped 5.16% to $20.30, representing a gain of $0.995 per share. Some 85,425 shares traded hands on 666 trades, compared with an average daily volume of 177,652 shares out of a total float of 21.51 million. The stock opened at $19.46 and traded with an intraday range of $20.39 to $19.40.

After today's gains, Global Brass & Copper Holdings Inc reached a market cap of $436.49 million. Global Brass & Copper Holdings Inc has had a trading range between $24.05 and $12.87 over the last year, and it had a 50-day SMA of $21.51 and a 200-day SMA of $19.33.

The stock has a P/E Ratio of 11.9.

Global Brass & Copper Holdings Inc is a fabricator, distributor & processor of specialized copper and brass products. It engages in metal melting & casting, rolling, drawing, extruding & stamping to fabricate finished & semi-finished alloy products.

Global Brass & Copper Holdings Inc is based out of Schaumburg, IL and has some 1,896 employees. Its CEO is John J. Wasz.

For a complete fundamental analysis analysis of Global Brass & Copper Holdings Inc, check out’s Stock Valuation Analysis report for BRSS. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.